149 related articles for article (PubMed ID: 12570340)
1. Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer.
Ashok BT; Chen YG; Liu X; Garikapaty VP; Seplowitz R; Tschorn J; Roy K; Mittelman A; Tiwari RK
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S86-93. PubMed ID: 12570340
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol.
Ashok BT; Chen Y; Liu X; Bradlow HL; Mittelman A; Tiwari RK
Nutr Cancer; 2001; 41(1-2):180-7. PubMed ID: 12094623
[TBL] [Abstract][Full Text] [Related]
3. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer.
Yuan F; Chen DZ; Liu K; Sepkovic DW; Bradlow HL; Auborn K
Anticancer Res; 1999; 19(3A):1673-80. PubMed ID: 10470100
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha as a target for indole-3-carbinol.
Wang TT; Milner MJ; Milner JA; Kim YS
J Nutr Biochem; 2006 Oct; 17(10):659-64. PubMed ID: 16488130
[TBL] [Abstract][Full Text] [Related]
5. Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells.
Chatterji U; Riby JE; Taniguchi T; Bjeldanes EL; Bjeldanes LF; Firestone GL
Carcinogenesis; 2004 Jul; 25(7):1119-28. PubMed ID: 14988219
[TBL] [Abstract][Full Text] [Related]
6. Effects of analogs of indole-3-carbinol cyclic trimerization product in human breast cancer cells.
Xue L; Schaldach CM; Janosik T; Bergman J; Bjeldanes LF
Chem Biol Interact; 2005 Apr; 152(2-3):119-29. PubMed ID: 15840385
[TBL] [Abstract][Full Text] [Related]
7. Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice.
Jin L; Qi M; Chen DZ; Anderson A; Yang GY; Arbeit JM; Auborn KJ
Cancer Res; 1999 Aug; 59(16):3991-7. PubMed ID: 10463597
[TBL] [Abstract][Full Text] [Related]
8. The anti-estrogenic activity of indole-3-carbinol in neonatal rat osteoblasts is associated with the estrogen receptor antagonist 2-hydroxyestradiol.
Enríquez J; Velázquez-Cruz R; Parra-Torres A; Gutiérrez-Sagal R; Larrea F
J Endocrinol Invest; 2016 Oct; 39(10):1149-58. PubMed ID: 27312859
[TBL] [Abstract][Full Text] [Related]
9. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent.
Tiwari RK; Guo L; Bradlow HL; Telang NT; Osborne MP
J Natl Cancer Inst; 1994 Jan; 86(2):126-31. PubMed ID: 8271295
[TBL] [Abstract][Full Text] [Related]
10. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes.
Meng Q; Qi M; Chen DZ; Yuan R; Goldberg ID; Rosen EM; Auborn K; Fan S
J Mol Med (Berl); 2000; 78(3):155-65. PubMed ID: 10868478
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol.
Kojima T; Tanaka T; Mori H
Cancer Res; 1994 Mar; 54(6):1446-9. PubMed ID: 8137246
[TBL] [Abstract][Full Text] [Related]
12. 3,3'-diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout.
Shilling AD; Carlson DB; Katchamart S; Williams DE
Toxicol Appl Pharmacol; 2001 Feb; 170(3):191-200. PubMed ID: 11162784
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells.
Zhang J; Hsu B A JC; Kinseth B A MA; Bjeldanes LF; Firestone GL
Cancer; 2003 Dec; 98(11):2511-20. PubMed ID: 14635088
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MUC1 expression by indole-3-carbinol.
Lee IJ; Han F; Baek J; Hisatsune A; Kim KC
Int J Cancer; 2004 May; 109(6):810-6. PubMed ID: 15027113
[TBL] [Abstract][Full Text] [Related]
15. Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells.
Meng Q; Yuan F; Goldberg ID; Rosen EM; Auborn K; Fan S
J Nutr; 2000 Dec; 130(12):2927-31. PubMed ID: 11110848
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of cancer with indole-3-carbinol.
Brignall MS
Altern Med Rev; 2001 Dec; 6(6):580-9. PubMed ID: 11804548
[TBL] [Abstract][Full Text] [Related]
17. 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer.
Garikapaty VP; Ashok BT; Tadi K; Mittelman A; Tiwari RK
Biochem Biophys Res Commun; 2006 Feb; 340(2):718-25. PubMed ID: 16380095
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
19. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.
Garikapaty VP; Ashok BT; Chen YG; Mittelman A; Iatropoulos M; Tiwari RK
Oncol Rep; 2005 Jan; 13(1):89-93. PubMed ID: 15583807
[TBL] [Abstract][Full Text] [Related]
20. 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.
Nguyen HH; Lavrenov SN; Sundar SN; Nguyen DH; Tseng M; Marconett CN; Kung J; Staub RE; Preobrazhenskaya MN; Bjeldanes LF; Firestone GL
Chem Biol Interact; 2010 Aug; 186(3):255-66. PubMed ID: 20570586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]